Quantummedi Formulation LLP

Quantummedi Formulation LLP - pharma in Kanpur, Uttar Pradesh, India. Directors, charges & compliance details.
LLPIN AAG-7936 Incorporated 28 June 2016 ROC Kanpur HQ Kanpur, Uttar Pradesh, India
Active Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
10 yrs
Est. 2016
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Kanpur
ROC office
Incorporated
28 Jun 2016
Date of incorporation

About Quantummedi Formulation LLP

Data last updated:

Quantummedi Formulation LLP is a limited liability partnership (LLP) based in Kanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 June 2016 and has been in existence for over 10 years.

The LLP is registered with the Registrar of Companies (ROC), Kanpur, under LLPIN AAG-7936. Its GSTIN is 09AAAFQ6348P1ZK (Uttar Pradesh).

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Sonila Arora and Vineet Arora.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 116 Kda Market Barra – 2 Opp Allahabad Bank, Kanpur, Uttar Pradesh, India – 208007.

Company Details of Quantummedi Formulation LLP
LLPIN AAG-7936
Incorporation Date 28 June 2016
Total Obligation of Contribution ₹1 Lakh
ROC Kanpur
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Sonila Arora Designated Partner Vineet Arora Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    116 Kda Market Barra – 2 Opp Allahabad Bank, Kanpur, Uttar Pradesh, India – 208007
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Quantummedi Formulation LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Quantummedi Formulation LLP report

Financials, compliance, directors, charges, ownership and filings for Quantummedi Formulation LLP in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Financials of Quantummedi Formulation LLP FY 2025 filings available

Financial Statement Summary of Quantummedi Formulation LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Quantummedi Formulation LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Quantummedi Formulation are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Quantummedi Formulation LLP

Quantummedi Formulation has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Sonila AroraDesignated Partner28 Jun 201610 Years 3 MonthsCurrent
Vineet AroraDesignated Partner28 Jun 201610 Years 3 MonthsCurrent
View all designated partners

Charges & Borrowings of Quantummedi Formulation LLP

Quantummedi Formulation LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Quantummedi Formulation LLP

Employment history and EPFO contributions of people linked to Quantummedi Formulation.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Quantummedi Formulation LLP

Quantummedi Formulation LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Sonila Arora was appointed as Designated Partner on 28 Jun 2016.

AGM
Quantummedi Formulation Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Quantummedi Formulation Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Sonila Arora was appointed as Designated Partner.
Appointed
Vineet Arora was appointed as Designated Partner.
Incorporation
28 Jun 2016
Quantummedi Formulation Llp was registered on 28 Jun 2016 with Roc Kanpur & aged 10 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Quantummedi Formulation LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Quantummedi Formulation LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Quantummedi Formulation LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Quantummedi Formulation LLP

Quantummedi Formulation has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAAFQ6348P1ZKUttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Quantummedi Formulation LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quantummedi Formulation LLP

Quantummedi Formulation is an active limited liability partnership based in Kanpur, Uttar Pradesh, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 28 June 2016 (10+ years old) and is registered under LLPIN AAG-7936.

Quantummedi Formulation has 2 current designated partners:

The GSTIN of Quantummedi Formulation is 09AAAFQ6348P1ZK, registered in Uttar Pradesh.

The LLPIN (Limited Liability Partnership Identification Number) of Quantummedi Formulation is AAG-7936. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Quantummedi Formulation was incorporated on 28 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.

Sonila Arora was appointed as Designated Partner on 28 Jun 2016. Vineet Arora was appointed as Designated Partner on 28 Jun 2016.

The registered office of Quantummedi Formulation is at 116 Kda Market Barra – 2 Opp Allahabad Bank, Kanpur, Uttar Pradesh, India – 208007.

The total obligation of contribution is ₹1 Lakh.

Quantummedi Formulation operates in the pharma industry, in the drug formulation and development segment.

Quantummedi Formulation can be reached at its registered office: 116 Kda Market Barra – 2 Opp Allahabad Bank, Kanpur, Uttar Pradesh, India – 208007.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available